Rxo (RXO) Equity Ratio (2021 - 2026)

Rxo (RXO) has reported Equity Ratio for 6 consecutive years, with 0.46 the latest figure, recorded in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.46, down 3.87% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.46 (down 3.87% YoY), and the FY2025 annual result was 0.47, changed 0.41% from the prior year.
• Equity Ratio was 0.46 for Q1 2026 at Rxo, down from 0.47 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.51 in Q3 2022 and troughed at 0.29 in Q4 2022.
• Average Equity Ratio over 5 years is 0.4, with a median of 0.46 recorded in 2026.
• Year-over-year, Equity Ratio tumbled 44.14% in 2022 and jumped 60.64% in 2024.
• Over 5 years, Equity Ratio stood at 0.29 in 2022, then advanced by 12.61% to 0.33 in 2023, then surged by 45.07% to 0.47 in 2024, then fell by 0.41% to 0.47 in 2025, then declined by 1.81% to 0.46 in 2026.
• Per Business Quant data, the three most recent Equity Ratio figures were 0.46 in Q1 2026, 0.47 in Q4 2025, and 0.49 in Q3 2025.